tiprankstipranks
Advertisement
Advertisement

CSTL Stock Latest News

Castle Biosciences to present new data from DecisionDx-Melanoma test at AAD
The FlyCastle Biosciences to present new data from DecisionDx-Melanoma test at AAD
7d ago
CSTL
Castle announces publication of DecisionDx-Melanoma’s i31-SLNB study results
PremiumThe Fly
Castle announces publication of DecisionDx-Melanoma’s i31-SLNB study results
21d ago
CSTL
Castle Biosciences announces new data from study evaluating i31SLNB
PremiumThe Fly
Castle Biosciences announces new data from study evaluating i31SLNB
26d ago
CSTL
Castle Biosciences Balances Strong Growth With Margin Strain
PremiumCompany Announcements
Castle Biosciences Balances Strong Growth With Margin Strain
28d ago
CSTL
Castle Biosciences: Strong Assay Momentum and Underpenetrated Market Support Buy Rating and $50 Price Target
PremiumRatings
Castle Biosciences: Strong Assay Momentum and Underpenetrated Market Support Buy Rating and $50 Price Target
1M ago
CSTL
Castle Biosciences price target raised to $44 from $41 at Baird
PremiumThe FlyCastle Biosciences price target raised to $44 from $41 at Baird
1M ago
CSTL
Castle Biosciences reports Q4 EPS (8c), consensus (26c)
Premium
The Fly
Castle Biosciences reports Q4 EPS (8c), consensus (26c)
1M ago
CSTL
Castle Biosciences sees 2026 revenue $340M-$350M, consensus $333.84M
Premium
The Fly
Castle Biosciences sees 2026 revenue $340M-$350M, consensus $333.84M
1M ago
CSTL
Castle Biosciences Posts Modest 2025 Growth Amid Headwinds
PremiumCompany Announcements
Castle Biosciences Posts Modest 2025 Growth Amid Headwinds
1M ago
8K
CSTL
Castle Biosciences price target raised to $50 from $36 at KeyBanc
PremiumThe Fly
Castle Biosciences price target raised to $50 from $36 at KeyBanc
2M ago
CSTL
Castle Biosciences price target raised to $47 from $43 at Guggenheim
PremiumThe Fly
Castle Biosciences price target raised to $47 from $43 at Guggenheim
2M ago
CSTL
Castle Biosciences Reports Strong Preliminary 2025 Revenue Growth
PremiumCompany Announcements
Castle Biosciences Reports Strong Preliminary 2025 Revenue Growth
3M ago
8K
CSTL
Castle Biosciences: Broad-Based Test Growth, Strengthening Cash Generation, and Pipeline Upside Support Reiterated Buy and $50 Target
PremiumRatingsCastle Biosciences: Broad-Based Test Growth, Strengthening Cash Generation, and Pipeline Upside Support Reiterated Buy and $50 Target
3M ago
CSTL
Castle Biosciences price target raised to $52 from $35 at Lake Street
Premium
The Fly
Castle Biosciences price target raised to $52 from $35 at Lake Street
3M ago
CSTL
Castle Biosciences expects FY25 revenue to exceed $340M
Premium
The Fly
Castle Biosciences expects FY25 revenue to exceed $340M
3M ago
CSTL
Castle Biosciences price target raised to $43 from $30 at Guggenheim
PremiumThe Fly
Castle Biosciences price target raised to $43 from $30 at Guggenheim
3M ago
CSTL
Castle Biosciences price target raised to $50 from $37 at Canaccord
PremiumThe Fly
Castle Biosciences price target raised to $50 from $37 at Canaccord
3M ago
CSTL
Castle Biosciences reports inducement grants under Nasdaq listing rule
PremiumThe Fly
Castle Biosciences reports inducement grants under Nasdaq listing rule
4M ago
CSTL
Castle Biosciences announces new data on DecisionDx-UM, PRAME
PremiumThe Fly
Castle Biosciences announces new data on DecisionDx-UM, PRAME
4M ago
CSTL
Castle Biosciences price target raised to $50 from $38 at BTIG
PremiumThe FlyCastle Biosciences price target raised to $50 from $38 at BTIG
4M ago
CSTL
Castle Biosciences announces publication of new SRMA on TissueCypher
Premium
The Fly
Castle Biosciences announces publication of new SRMA on TissueCypher
4M ago
CSTL
Castle announces publication of consensus paper on DecisionDx-Melanoma test
Premium
The Fly
Castle announces publication of consensus paper on DecisionDx-Melanoma test
4M ago
CSTL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >